AIP.NASDAQArteris, INC

Form 4: Arteris Director Kunkel Boosts Stake with Stock Compensation

Sentiment:

Insider Transaction Report


Arteris, Inc. Director Joachim Kunkel acquired 1,496 shares of common stock as fully vested restricted stock in lieu of cash retainer fees.

Summary

  • Joachim Kunkel, a Director of Arteris, Inc. (AIP), acquired 1,496 shares of common stock.
  • The acquisition occurred on October 5, 2025.
  • These shares represent fully vested restricted stock, received as retainer fees in lieu of cash compensation.
  • The transaction price per share was $0.00, indicating an award rather than a purchase.
  • Following this transaction, Kunkel beneficially owns 67,818 shares of Arteris, Inc. common stock.
  • Kunkel elected to defer the receipt of these shares.

Sentiment

Score: 6

Explanation: Slightly positive as a director is increasing their stake in the company through compensation, aligning interests with shareholders. This is a routine event and not indicative of major news.

Positives

  • Director Joachim Kunkel increased his beneficial ownership in Arteris, Inc. by 1,496 shares, aligning his interests further with shareholders.
  • The shares were received as fully vested restricted stock, indicating a commitment to the company's long-term performance.
  • The election to receive shares in lieu of cash for retainer fees demonstrates confidence in the company's equity value.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing is a routine disclosure of insider stock ownership changes, common across all publicly traded industries. It reflects a director's compensation structure rather than broader industry trends or competitive positioning.

Related Party Transactions

  • The transaction involves a director receiving shares as compensation, which is a related party transaction, but it is a standard form of compensation disclosed transparently.

Stakeholder Impact

  • Shareholders: Positive impact as the director's increased equity stake aligns their interests more closely with those of other shareholders.
  • Employees: No direct impact mentioned.
  • Customers/Suppliers/Creditors: No direct impact mentioned.

Key Dates

DateDescription
10/05/2025Date of transaction where Joachim Kunkel acquired 1,496 shares of common stock.
10/06/2025Date the Form 4 was signed by Paul Alpern as Attorney-in-fact for Joachim Kunkel.

Keywords

Arteris Inc., AIP, Joachim Kunkel, Director, Insider Trading, Form 4, Stock Compensation, Restricted Stock, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.